Workday Inc. President Gerrit S. Kazmaier reported two recent stock dispositions in filings with the Securities and Exchange Commission. According to a Form 4, Kazmaier sold 9,356 shares of Class A Common Stock on April 7, 2026, at $128.39 per share, producing proceeds of approximately $1.2 million.
The filing also shows a separate disposal of 12,270 shares on April 5, 2026. That tranche was sold to satisfy tax obligations tied to vesting restricted stock units and was executed at $132.26 per share, for total consideration of about $1.6 million.
Following the April transactions, Kazmaier directly holds 165,074 shares of Workday Class A Common Stock. That total includes 161,956 restricted stock units.
The April 7 sale was carried out under a pre-arranged Rule 10b5-1 trading plan that Kazmaier adopted on September 19, 2025, according to the filing.
Workday’s shares were trading at $127.51 at the time of the report, close to their 52-week low of $117.76 and down 45% over the past six months. InvestingPro analysis cited in the filing indicates a Fair Value of $202.59 for the stock - placing it on InvestingPro’s Most Undervalued list. The company is noted as having a market capitalization of $32.8 billion and, according to InvestingPro Tips, holding more cash than debt on its balance sheet. The filing also points readers to a more comprehensive Pro Research Report on Workday, one of more than 1,400 reports available through the platform.
Corporate results and analyst moves are noted alongside the insider activity. Workday reported solid Q4 FY2026 results, meeting revenue forecasts and exceeding earnings expectations. The company’s operating margin improved in the quarter, a change attributed to a slower hiring pace.
Following the quarterly results, several brokerages adjusted their price targets. DA Davidson lowered its target to $125 from $250, citing guidance that fell short of revenue and profitability expectations. BMO Capital reduced its target to $182 from $204, highlighting concerns about growth uncertainties tied to generative AI and agentic capabilities. Freedom Capital Markets trimmed its target to $210 from $280 while maintaining a Buy rating, citing competitive risks from AI.
Board-level and customer developments were also disclosed. Workday’s Board of Directors granted CEO Aneel Bhusri restricted stock unit awards covering 437,602 shares; those awards will vest over four years. Separately, Fairview Health Services selected Workday to modernize its human resources, finance, and supply chain systems, with an anticipated transition of 34,000 employees to Workday’s integrated platform.
Context and implications
The Form 4 filing documents routine insider activity including a Rule 10b5-1 plan sale and a tax-related disposition tied to vested equity. The filings place the transactions in the context of the company’s near-term operating results, analyst reassessments of valuation and growth prospects, and recent corporate actions affecting senior leadership and client deployments.